(Q35970415)

11 August 2017

1 reference

title

Design of inhibitors against HIV, HTLV-I, and Plasmodium falciparum aspartic proteases (English)

1 reference

Human T-lymphotropic virus 1

11 August 2017

Plasmodium falciparum

0 references

0 references

author name string

Hamdy M Abdel-Rahman

1

1 reference

11 August 2017

Tooru Kimura

2

1 reference

11 August 2017

Koushi Hidaka

3

1 reference

11 August 2017

Aiko Kiso

4

1 reference

11 August 2017

Azin Nezami

5

1 reference

11 August 2017

Ernesto Freire

6

1 reference

11 August 2017

Yoshio Hayashi

7

1 reference

11 August 2017

Yoshiaki Kiso

8

1 reference

11 August 2017

1 November 2004

1 reference

11 August 2017

1 reference

11 August 2017

385

1 reference

11 August 2017

1035-1039

1 reference

11 August 2017

11

1 reference

Inhibitors of the Plasmodium falciparum parasite aspartic protease plasmepsin II as potential antimalarial agents

11 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.134

Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.134

Design and synthesis of substrate-based peptidomimetic human immunodeficiency virus protease inhibitors containing the hydroxymethylcarbonyl isostere

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.134

Effects of nucleoside-based antiretroviral chemotherapy on human T cell leukaemia/lymphotropic virus type 1 (HTLV-1) infection in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.134

Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.134

Structure-activity and structure-metabolism relationships of HIV protease inhibitors containing the 3-hydroxy-2-methylbenzoyl-allophenylnorstatine structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.134

Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.134

High-affinity inhibition of a family of Plasmodium falciparum proteases by a designed adaptive inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.134

Anisotropic dynamics of the JE-2147-HIV protease complex: drug resistance and thermodynamic binding mode examined in a 1.09 A structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.134

Understanding HTLV-I protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.134

A structural and thermodynamic escape mechanism from a drug resistant mutation of the HIV-1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.134

The binding energetics of first- and second-generation HIV-1 protease inhibitors: implications for drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.134

JE-2147: a dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2004.134

21 January 2018

Identifiers

DOI

10.1515/BC.2004.134

1 reference

11 August 2017

1 reference